Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Ellis, E; Wagner, M; Lammert, F; Nemeth, A; Gumhold, J; Strassburg, CP; Kylander, C; Katsika, D; Trauner, M; Einarsson, C; Marschall, HU.
Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin.
J HEPATOL. 2006; 44(1): 243-245.
Doi: 10.1016/j.jhep.2005.09.011
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
-
Sommer Judith
-
Trauner Michael
-
Wagner Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
We report two patients with uncommon Gilbert's syndrome with severe unconjugated hyperbilirubinemia which was reduced from 200 to 60-90 micromol/L by long-term administration of rifampicin. Hepatic induction of bilirubin-glucuronosyltransferase was suggested by increased relative amounts of conjugated serum bilirubin. This molecular mechanism was confirmed in primary cultures of human hepatocytes.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Bilirubin - blood
-
Cells, Cultured -
-
Enzyme Inhibitors - therapeutic use
-
Female -
-
Follow-Up Studies -
-
Gilbert Disease - blood Gilbert Disease - drug therapy Gilbert Disease - pathology
-
Glucuronosyltransferase - antagonists & inhibitors Glucuronosyltransferase - blood
-
Hepatocytes - pathology
-
Humans -
-
Male -
-
Rifampin - therapeutic use
-
Time Factors -
- Find related publications in this database (Keywords)
-
Gilbert
-
jaundice
-
glucuronosyltransferase
-
cultured human hepatocytes